LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: Covalent Inactivation of

    Pham, Truc Viet / Mellott, Drake M / Moghadamchargari, Zahra / Chen, Kevin / Krieger, Inna / Laganowsky, Arthur / Sacchettini, James C / Meek, Thomas D

    ACS chemical biology

    2021  Volume 16, Issue 3, Page(s) 463–470

    Abstract: The isocitrate lyases (ICL1/2) are essential enzymes ... ...

    Abstract The isocitrate lyases (ICL1/2) are essential enzymes of
    MeSH term(s) Antitubercular Agents/chemistry ; Antitubercular Agents/metabolism ; Drug Discovery ; Enzyme Activation/drug effects ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/metabolism ; Escherichia coli/metabolism ; Glycolates/chemistry ; Glyoxylates/chemistry ; Humans ; Isocitrate Lyase/antagonists & inhibitors ; Isomerism ; Models, Molecular ; Mycobacterium tuberculosis/enzymology ; Protein Binding ; Protein Conformation ; Proteomics ; Succinates/chemistry ; Succinates/metabolism ; Thermodynamics ; Tuberculosis/drug therapy
    Chemical Substances Antitubercular Agents ; Enzyme Inhibitors ; Glycolates ; Glyoxylates ; Succinates ; glycolic acid (0WT12SX38S) ; 2,3-epoxysuccinic acid (3272-11-5) ; Isocitrate Lyase (EC 4.1.3.1) ; glyoxylic acid (JQ39C92HH6)
    Language English
    Publishing date 2021-03-10
    Publishing country United States
    Document type Journal Article
    ISSN 1554-8937
    ISSN (online) 1554-8937
    DOI 10.1021/acschembio.0c00740
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Dinitrosyl iron complexes (DNICs) as inhibitors of the SARS-CoV-2 main protease.

    Pectol, D Chase / DeLaney, Christopher R / Zhu, Jiyun / Mellott, Drake M / Katzfuss, Ardala / Taylor, Zane W / Meek, Thomas D / Darensbourg, Marcetta Y

    Chemical communications (Cambridge, England)

    2021  Volume 57, Issue 67, Page(s) 8352–8355

    Abstract: By repurposing DNICs designed for other medicinal purposes, the possibility of protease inhibition was investigated in silico using AutoDock 4.2.6 (AD4) and in vitro via a FRET protease assay. AD4 was validated as a predictive computational tool for ... ...

    Abstract By repurposing DNICs designed for other medicinal purposes, the possibility of protease inhibition was investigated in silico using AutoDock 4.2.6 (AD4) and in vitro via a FRET protease assay. AD4 was validated as a predictive computational tool for coordinatively unsaturated DNIC binding using the only known crystal structure of a protein-bound DNIC, PDB- (calculation RMSD = 1.77). From the in silico data the dimeric DNICs TGTA-RRE, [(μ-S-TGTA)Fe(NO)
    MeSH term(s) Dose-Response Relationship, Drug ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/pharmacology ; Humans ; Iron/chemistry ; Iron/pharmacology ; Models, Molecular ; Molecular Structure ; Nitrogen Oxides/chemistry ; Nitrogen Oxides/pharmacology ; Peptide Hydrolases/metabolism ; SARS-CoV-2/drug effects ; SARS-CoV-2/enzymology
    Chemical Substances Enzyme Inhibitors ; Nitrogen Oxides ; dinitrosyl iron complex (68586-27-6) ; Iron (E1UOL152H7) ; Peptide Hydrolases (EC 3.4.-)
    Language English
    Publishing date 2021-08-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 1472881-3
    ISSN 1364-548X ; 1359-7345 ; 0009-241X
    ISSN (online) 1364-548X
    ISSN 1359-7345 ; 0009-241X
    DOI 10.1039/d1cc03103a
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents.

    Zhu, Jiyun / Li, Linfeng / Drelich, Aleksandra / Chenna, Bala C / Mellott, Drake M / Taylor, Zane W / Tat, Vivian / Garcia, Christopher Z / Katzfuss, Ardala / Tseng, Chien-Te K / Meek, Thomas D

    Frontiers in chemistry

    2022  Volume 10, Page(s) 867928

    Abstract: Cysteine proteases comprise an important class of drug targets, especially for infectious diseases such as Chagas disease (cruzain) and COVID-19 (3CL protease, cathepsin L). Peptide aldehydes have proven to be potent inhibitors for all of these proteases. ...

    Abstract Cysteine proteases comprise an important class of drug targets, especially for infectious diseases such as Chagas disease (cruzain) and COVID-19 (3CL protease, cathepsin L). Peptide aldehydes have proven to be potent inhibitors for all of these proteases. However, the intrinsic, high electrophilicity of the aldehyde group is associated with safety concerns and metabolic instability, limiting the use of aldehyde inhibitors as drugs. We have developed a novel class of compounds, self-masked aldehyde inhibitors (SMAIs) which are based on the dipeptide aldehyde inhibitor (Cbz-Phe-Phe-CHO,
    Language English
    Publishing date 2022-07-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2711776-5
    ISSN 2296-2646
    ISSN 2296-2646
    DOI 10.3389/fchem.2022.867928
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Mechanism-Based Inactivation of Mycobacterium tuberculosis Isocitrate Lyase 1 by (2R,3S)-2-Hydroxy-3-(nitromethyl)succinic acid

    Mellott, Drake M. / Torres, Dan / Krieger, Inna V. / Cameron, Scott A. / Moghadamchargari, Zahra / Laganowsky, Arthur / Sacchettini, James C. / Meek, Thomas D. / Harris, Lawrence D.

    Journal of the American Chemical Society. 2021 Oct. 19, v. 143, no. 42

    2021  

    Abstract: ... efficient mechanism-based inactivator of ICL1 (kᵢₙₐcₜ/KI = (1.3 ± 0.1) × 10³ M–¹ s–¹) with a partition ratio ... will simplify the synthesis of pro-drug forms of 5-NIC for characterization in cell-infection models of M ...

    Abstract The isocitrate lyase paralogs of Mycobacterium tuberculosis (ICL1 and 2) are essential for mycobacterial persistence and constitute targets for the development of antituberculosis agents. We report that (2R,3S)-2-hydroxy-3-(nitromethyl)succinic acid (5-NIC) undergoes apparent retro-aldol cleavage as catalyzed by ICL1 to produce glyoxylate and 3-nitropropionic acid (3-NP), the latter of which is a covalent-inactivating agent of ICL1. Kinetic analysis of this reaction identified that 5-NIC serves as a robust and efficient mechanism-based inactivator of ICL1 (kᵢₙₐcₜ/KI = (1.3 ± 0.1) × 10³ M–¹ s–¹) with a partition ratio <1. Using enzyme kinetics, mass spectrometry, and X-ray crystallography, we identified that the reaction of the 5-NIC-derived 3-NP with the Cys₁₉₁ thiolate of ICL1 results in formation of an ICL1-thiohydroxamate adduct as predicted. One aspect of the design of 5-NIC was to lower its overall charge compared to isocitrate to assist with cell permeability. Accordingly, the absence of the third carboxylate group will simplify the synthesis of pro-drug forms of 5-NIC for characterization in cell-infection models of M. tuberculosis.
    Keywords 3-nitropropionic acid ; Mycobacterium tuberculosis ; X-ray diffraction ; enzyme kinetics ; isocitrate lyase ; kinetics ; mass spectrometry ; permeability ; succinic acid
    Language English
    Dates of publication 2021-1019
    Size p. 17666-17676.
    Publishing place American Chemical Society
    Document type Article
    ZDB-ID 3155-0
    ISSN 1520-5126 ; 0002-7863
    ISSN (online) 1520-5126
    ISSN 0002-7863
    DOI 10.1021/jacs.1c07970
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: Mechanism-Based Inactivation of

    Mellott, Drake M / Torres, Dan / Krieger, Inna V / Cameron, Scott A / Moghadamchargari, Zahra / Laganowsky, Arthur / Sacchettini, James C / Meek, Thomas D / Harris, Lawrence D

    Journal of the American Chemical Society

    2021  Volume 143, Issue 42, Page(s) 17666–17676

    Abstract: The isocitrate lyase paralogs ... ...

    Abstract The isocitrate lyase paralogs of
    MeSH term(s) Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/metabolism ; Glyoxylates/chemistry ; Glyoxylates/metabolism ; Isocitrate Lyase/antagonists & inhibitors ; Isocitrate Lyase/chemistry ; Isocitrate Lyase/metabolism ; Kinetics ; Models, Chemical ; Mycobacterium tuberculosis/enzymology ; Nitro Compounds/chemistry ; Nitro Compounds/metabolism ; Propionates/chemistry ; Propionates/metabolism ; Protein Binding ; Succinates/chemical synthesis ; Succinates/chemistry ; Succinates/metabolism
    Chemical Substances Enzyme Inhibitors ; Glyoxylates ; Nitro Compounds ; Propionates ; Succinates ; Isocitrate Lyase (EC 4.1.3.1) ; glyoxylic acid (JQ39C92HH6) ; 3-nitropropionic acid (QY4L0FOX0D)
    Language English
    Publishing date 2021-10-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3155-0
    ISSN 1520-5126 ; 0002-7863
    ISSN (online) 1520-5126
    ISSN 0002-7863
    DOI 10.1021/jacs.1c07970
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Self-Masked Aldehyde Inhibitors of Human Cathepsin L Are Potent Anti-CoV-2 Agents

    Jiyun Zhu / Linfeng Li / Aleksandra Drelich / Bala C. Chenna / Drake M. Mellott / Zane W. Taylor / Vivian Tat / Christopher Z. Garcia / Ardala Katzfuss / Chien-Te K. Tseng / Thomas D. Meek

    Frontiers in Chemistry, Vol

    2022  Volume 10

    Abstract: ... to be potent anti-SARS-CoV-2 agents in infected mammalian cells (Mellott et al. (2021) ACS Chem. Biol ...

    Abstract Cysteine proteases comprise an important class of drug targets, especially for infectious diseases such as Chagas disease (cruzain) and COVID-19 (3CL protease, cathepsin L). Peptide aldehydes have proven to be potent inhibitors for all of these proteases. However, the intrinsic, high electrophilicity of the aldehyde group is associated with safety concerns and metabolic instability, limiting the use of aldehyde inhibitors as drugs. We have developed a novel class of compounds, self-masked aldehyde inhibitors (SMAIs) which are based on the dipeptide aldehyde inhibitor (Cbz-Phe-Phe-CHO, 1), for which the P1 Phe group contains a 1′-hydroxy group, effectively, an o-tyrosinyl aldehyde (Cbz-Phe-o-Tyr-CHO, 2; (Li et al. (2021) J. Med. Chem. 64, 11,267–11,287)). Compound 2 and other SMAIs exist in aqueous mixtures as stable δ-lactols, and apparent catalysis by the cysteine protease cruzain, the major cysteine protease of Trypanosoma cruzi, results in the opening of the lactol ring to afford the aldehydes which then form reversible thiohemiacetals with the enzyme. These SMAIs are also potent, time-dependent inhibitors of human cathepsin L (Ki = 11–60 nM), an enzyme which shares 36% amino acid identity with cruzain. As inactivators of cathepsin L have recently been shown to be potent anti-SARS-CoV-2 agents in infected mammalian cells (Mellott et al. (2021) ACS Chem. Biol. 16, 642–650), we evaluated SMAIs in VeroE6 and A549/ACE2 cells infected with SARS-CoV-2. These SMAIs demonstrated potent anti-SARS-CoV-2 activity with values of EC50 = 2–8 μM. We also synthesized pro-drug forms of the SMAIs in which the hydroxyl groups of the lactols were O-acylated. Such pro-drug SMAIs resulted in significantly enhanced anti-SARS-CoV-2 activity (EC50 = 0.3–0.6 μM), demonstrating that the O-acylated-SMAIs afforded a level of stability within infected cells, and are likely converted to SMAIs by the action of cellular esterases. Lastly, we prepared and characterized an SMAI in which the sidechain adjacent to the terminal aldehyde is a ...
    Keywords SARS coronavirus-2 ; cathepsin L ; self-masked aldehydes ; reversible covalent inactivation ; COVID-19 ; cysteine proteases ; Chemistry ; QD1-999
    Subject code 540
    Language English
    Publishing date 2022-07-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Bepridil is potent against SARS-CoV-2 in vitro.

    Vatansever, Erol C / Yang, Kai S / Drelich, Aleksandra K / Kratch, Kaci C / Cho, Chia-Chuan / Kempaiah, Kempaiah Rayavara / Hsu, Jason C / Mellott, Drake M / Xu, Shiqing / Tseng, Chien-Te K / Liu, Wenshe Ray

    Proceedings of the National Academy of Sciences of the United States of America

    2021  Volume 118, Issue 10

    Abstract: ... of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (M ...

    Abstract Guided by a computational docking analysis, about 30 Food and Drug Administration/European Medicines Agency (FDA/EMA)-approved small-molecule medicines were characterized on their inhibition of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (M
    MeSH term(s) A549 Cells ; Animals ; Antiviral Agents/pharmacology ; Bepridil/pharmacology ; Chlorocebus aethiops ; Drug Discovery ; Humans ; Molecular Docking Simulation ; Molecular Structure ; SARS-CoV-2/drug effects ; Small Molecule Libraries ; Vero Cells
    Chemical Substances Antiviral Agents ; Small Molecule Libraries ; Bepridil (755BO701MA)
    Language English
    Publishing date 2021-02-17
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2012201118
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Bepridil is potent against SARS-CoV-2 In Vitro.

    Vatansever, Erol C / Yang, Kai / Kratch, Kaci C / Drelich, Aleksandra / Cho, Chia-Chuan / Mellott, Drake M / Xu, Shiqing / Tseng, Chien-Te K / Liu, Wenshe Ray

    bioRxiv : the preprint server for biology

    2020  

    Abstract: ... characterized on their inhibition of the SARS-CoV-2 main protease (M ...

    Abstract Guided by a computational docking analysis, about 30 FDA/EMA-approved small molecule medicines were characterized on their inhibition of the SARS-CoV-2 main protease (M
    Keywords covid19
    Language English
    Publishing date 2020-07-27
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2020.05.23.112235
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Dinitrosyl iron complexes (DNICs) as inhibitors of the SARS-CoV-2 main protease

    Pectol, D. Chase / DeLaney, Christopher R. / Zhu, Jiyun / Mellott, Drake M. / Katzfuss, Ardala / Taylor, Zane W. / Meek, Thomas D. / Darensbourg, Marcetta Y.

    Chemical communications. 2021 Aug. 19, v. 57, no. 67

    2021  

    Abstract: By repurposing DNICs designed for other medicinal purposes, the possibility of protease inhibition was investigated in silico using AutoDock 4.2.6 (AD4) and in vitro via a FRET protease assay. AD4 was validated as a predictive computational tool for ... ...

    Abstract By repurposing DNICs designed for other medicinal purposes, the possibility of protease inhibition was investigated in silico using AutoDock 4.2.6 (AD4) and in vitro via a FRET protease assay. AD4 was validated as a predictive computational tool for coordinatively unsaturated DNIC binding using the only known crystal structure of a protein-bound DNIC, PDB–1ZGN (calculation RMSD = 1.77). From the in silico data the dimeric DNICs TGTA–RRE, [(μ-S-TGTA)Fe(NO)₂]₂ (TGTA = 1-thio-β-d-glucose tetraacetate) and TG–RRE, [(μ-S-TG)Fe(NO)₂]₂ (TG = 1-thio-β-d-glucose) were identified as promising leads for inhibition via coordinative inhibition at Cys-145 of the SARS-CoV-2 Main Protease (SC2Mᵖʳᵒ). In vitro studies indicate inhibition of protease activity upon DNIC treatment, with an IC₅₀ of 38 ± 2 μM for TGTA–RRE and 33 ± 2 μM for TG–RRE. This study presents a simple computational method for predicting DNIC–protein interactions; the in vitro study is consistent with in silico leads.
    Keywords computer simulation ; crystal structure ; enzyme activity ; proteinases
    Language English
    Dates of publication 2021-0819
    Size p. 8352-8355.
    Publishing place The Royal Society of Chemistry
    Document type Article
    ZDB-ID 1472881-3
    ISSN 1364-548X ; 1359-7345 ; 0009-241X
    ISSN (online) 1364-548X
    ISSN 1359-7345 ; 0009-241X
    DOI 10.1039/d1cc03103a
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity.

    Chenna, Bala C / Li, Linfeng / Mellott, Drake M / Zhai, Xiang / Siqueira-Neto, Jair L / Calvet Alvarez, Claudia / Bernatchez, Jean A / Desormeaux, Emily / Alvarez Hernandez, Elizabeth / Gomez, Jana / McKerrow, James H / Cruz-Reyes, Jorge / Meek, Thomas D

    Journal of medicinal chemistry

    2020  Volume 63, Issue 6, Page(s) 3298–3316

    Abstract: Cruzain, an essential cysteine protease of the parasitic protozoan, ...

    Abstract Cruzain, an essential cysteine protease of the parasitic protozoan,
    MeSH term(s) Animals ; Cysteine Endopeptidases/metabolism ; Cysteine Proteinase Inhibitors/chemical synthesis ; Cysteine Proteinase Inhibitors/metabolism ; Cysteine Proteinase Inhibitors/pharmacology ; Drug Design ; Enzyme Assays ; Humans ; Kinetics ; Mice ; Molecular Docking Simulation ; Myoblasts, Cardiac/drug effects ; Peptidomimetics/chemical synthesis ; Peptidomimetics/metabolism ; Peptidomimetics/pharmacology ; Protein Binding ; Protozoan Proteins/antagonists & inhibitors ; Protozoan Proteins/metabolism ; Pyridines/chemical synthesis ; Pyridines/metabolism ; Pyridines/pharmacology ; Pyrimidines/chemical synthesis ; Pyrimidines/metabolism ; Pyrimidines/pharmacology ; Trypanocidal Agents/chemical synthesis ; Trypanocidal Agents/metabolism ; Trypanocidal Agents/pharmacology ; Trypanosoma brucei brucei/drug effects ; Trypanosoma cruzi/drug effects ; Vinyl Compounds/chemical synthesis ; Vinyl Compounds/metabolism ; Vinyl Compounds/pharmacology
    Chemical Substances Cysteine Proteinase Inhibitors ; Peptidomimetics ; Protozoan Proteins ; Pyridines ; Pyrimidines ; Trypanocidal Agents ; Vinyl Compounds ; Cysteine Endopeptidases (EC 3.4.22.-) ; cruzipain (EC 3.4.22.51)
    Language English
    Publishing date 2020-03-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.9b02078
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top